Page last updated: 2024-11-05

tyrphostin a9 and Glioma

tyrphostin a9 has been researched along with Glioma in 1 studies

Glioma: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Yadav, N1
Babu, D1
Madigubba, S1
Panigrahi, M1
Phanithi, PB1

Other Studies

1 other study available for tyrphostin a9 and Glioma

ArticleYear
Tyrphostin A9 attenuates glioblastoma growth by suppressing PYK2/EGFR-ERK signaling pathway.
    Journal of neuro-oncology, 2023, Volume: 163, Issue:3

    Topics: Animals; Astrocytoma; ErbB Receptors; Focal Adhesion Kinase 2; Glioblastoma; Glioma; Phosphorylation

2023